Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leak

Moderna’s stock suffered a sharp decline after a leak involving data from a cancer vaccine. The company’s shares fell 25%, resulting in an estimated loss of about $24 billion in market value.

Major market reaction

The drop represents a significant setback for Moderna in the stock market. The reported data leak directly coincided with the steep decline in the company’s share price, making it the central development affecting investors in the available information.

Focus on cancer vaccine data

The leak concerns data connected with Moderna’s cancer vaccine. No additional details about the leaked information, the circumstances surrounding the disclosure or the company’s response are available in the source material.

For now, the reported 25% fall and roughly $24 billion reduction in value mark the immediate market impact associated with the leak.